Safety Study of Ivacaftor in Subjects With Cystic Fibrosis
Clinical trial NCT00457821 · COMPLETED
Trial details
- NCT number
- NCT00457821
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-08-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.